Is an anticancer immune response mandatory for therapeutic success

Laurence Zitvogel; Lionel Apétoh; François Ghiringhelli; Fabrice André; Antoine Tesnière; Guido Guido Kroemer

Related publications

Article2008

The anticancer immune response: indispensable for therapeutic success?

Laurence Zitvogel, Lionel Apétoh, François Ghiringhelli, Fabrice André, Antoine Tesnière, Guido Guido Kroemer

Article2013

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy

Yuting Ma, Takahiro Yamazaki, Heng Yang, Oliver Kepp, Lorenzo Galluzzi, Laurence Zitvogel, Mark J. Smyth, Guido Guido Kroemer

Article2014

An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy

Mickaël Michaud, Xiaoqi Xie, José Manuel Bravo‐San Pedro, Laurence Zitvogel, Eileen White, Guido Guido Kroemer

Article2021

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Fabio Conforti, Laura Pala, Eleonora Pagan, Vincenzo Bagnardi, Tommaso De Pas, Paola Queirolo, Elisabetta Pennacchioli, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci, Maristella Saponara, Gianmarco Orsolini, Paola Zagami, Eleonora Nicolò, Filippo de Marinis, Giampaolo Tortora, Emilio Bria, Saverio Minucci, Hadine Joffe, Paolo Veronesi, Jennifer A. Wargo, Rachel Rosenthal, Charles Swanton, Alberto Mantovani,

Article2011

Prognostic impact of anticancer immune responses: an introduction

Franck Pagès, Guido Guido Kroemer